Skip to search.
 TSX Up 0.60% TSX Ventures Up 1.02%

Eli Lilly and Company (LLY)

-NYSE
84.51 Jul 31, 4:04PM EDT
|Pre-Market : 84.45 Down 0.06 (0.07%) 8:32AM EDT - Nasdaq Real Time Price
Add to Portfolio
Prev Close:84.51
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:89.82
Beta:0.29
Next Earnings Date:22-Oct-15LLY Earnings announcement
Day's Range:N/A - N/A
52wk Range:60.14 - 90.18
Volume:0
Avg Vol (3m):5,447,580
Market Cap:89.50B
P/E (ttm):43.81
EPS (ttm):1.93
Div & Yield:2.00 (2.40%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
LLY 0.00%89.50B
GSK104.91B
PFE222.05B
SNY141.18B

Key Statistics

Forward P/E (1 yr):23.67
P/S (ttm):4.59
Ex-Dividend Date:12-Aug-15

Analysts

Annual EPS Est (Dec-15) :3.27
Quarterly EPS Est (Sep-15) :0.75
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):2.53

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products worldwide. It operates in two segments, Human Pharmaceutical Products and Animal Health products. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback